Cargando…
Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
BACKGROUND: The use of cannabis for treating fibromyalgia syndrome (FMS) has not been comprehensively investigated. Thus, we have assessed the efficacy and adverse events (AEs) of short- and long-term medical cannabis (MC) treatment for FMS. METHODS: Data were obtained from medical reports archived...
Autor principal: | Mazza, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890993/ https://www.ncbi.nlm.nih.gov/pubmed/33597032 http://dx.doi.org/10.1186/s42238-021-00060-6 |
Ejemplares similares
-
Safety and Efficacy of Medical Cannabis in Fibromyalgia
por: Sagy, Iftach, et al.
Publicado: (2019) -
Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination—the SPIRAL study
por: van Dam, Cornelis Jan, et al.
Publicado: (2023) -
The role of cannabis in treatment‐resistant fibromyalgia women
por: Hershkovich, Oded, et al.
Publicado: (2022) -
Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
por: Morillas-Arques, Piedad, et al.
Publicado: (2010) -
Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
por: Anis, Saar, et al.
Publicado: (2022)